November 27-28 2024
Lyon, France
November 27-28 2024
Lyon, France
Contact MabDesign
Laure Delhon
17 rue Crépet
69007 Lyon
+33 (0)4 78 02 39 92
laure.delhon@mabdesign.fr
www.mabdesign.fr
Contact Lyonbiopôle
Natalia Bomchil
Bâtiment EKLAA
63 avenue Tony Garnier
69007 Lyon
+33 (0)4 72 76 53 36
natalia.bomchil@lyonbiopole.com
www.lyonbiopole.com
I4ID – Terms & conditions – Cookies – Design by IGTech
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 100,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.
Booth N°13 | www.sanofi.fr
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Dynamic Biosensors is part of Bruker Biosensors and provides instruments and consumables for the advanced analysis of biomolecular interactions on biochips and single cells, which enable breakthroughs in drug discovery, life science research, and cell & gene therapies.
Bruker Biosensors commercializes switchSENSE® , single-cell Interaction Cytometry (scIC) and Surface Plasmon Resonance (SPR) technologies. switchSENSE® is a unique platform technology for the analysis of molecule-molecule interactions. scIC is a groundbreaking technology enabling the real-time measurement of molecules binding to membrane targets on cells. SPR offers the analysis of molecular interactions in a high-throughput manner.
Dynamic Biosensors is headquartered in Munich, Germany.
Booth N°10 | https://www.dynamic-biosensors.com/ | info@dynamic-biosensors.com
As a global leader in analytical laboratory technologies, Agilent provides trusted answers to our customers’ most critical questions and challenges. Leveraging more than 50 years of laboratory, clinical, and enterprise level expertise, we produce advanced instruments, software and consumables, supported by teams of highly skilled and knowledgeable people. We combine all that to provide the most comprehensive solutions available today.
Solutions that produce the most accurate and reliable results as well as optimal scientific, economic, and operational outcomes. Solutions that help customers in food, pharma, environment, energy, chemical, forensics, academic research and clinical fields.
Booth N°5 | https://www.agilent.com/
ERBC Group is a 50 years’ leading CRO committed to bridge the gap between preclinical and clinical research by better predicting the efficacy and safety of new compounds offering innovative in vitro and in vivo translational models and services.
Offering a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services, ERBC allows biopharmaceutical and chemical industry professionals to de-risk innovation and enhance R&D productivity.
With highly qualified teams in France and Italy, ERBC is offering a customer-centric approach while committed in improving all aspects of study design and conduct applying alternatives to animal testing as a priority.
With extensive expertise in efficacy and biodistribution studies, ERBC provides exceptional support to oncology, immuno-oncology, infectious diseases, musculoskeletal disorders, and implant development programs. Specifically for infectious diseases, we offer cutting-edge services such as advanced imaging, qPCR, PFU assays, and specialized rodent models for both novel and drug-resistant bacterial infections, as well as respiratory viral infections. In 2020, at the forefront of drug innovation, by leveraging our state-of-the-art BSL3 laboratories, we proudly ranked among the top three CROs to develop, characterize, and supply ready-to-use hACE2 transgenic mouse and hamster models for SARS-CoV-2 infection research.
Booth N°4 | https://www.erbc-group.com/
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, metabolic and infectious diseases.With a product profile proven to stabilise, solubilise and to deliver the most challenging of active pharmaceutical ingredients and a substantial investment in GMP and multi-site EXCiPACT accreditation, Croda Pharma demonstrates confidence in both excipient quality and supply chain security.
Booth N°15 | www.evotec.com | info@evotec.com
Kymos Group is an analytical CRO with three European laboratories devoted to providing bioanalytical and CMC services for the life science industry throughout the entire product life cycle: from early research and development to manufacturing and commercialization. We are GLP- and GMP-certified, EMA and FDA inspected and are experts in analytical and quality control work with small molecules, biologics and oligonucleotides. Kymos provides services to clients worldwide in the pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetic and nutraceutical industries.
Booth N°8 | www.kymos.com I commercial@kymos.com
Beckman Coulter Life Sciences is dedicated to developing and providing advanced technologies and equipment for research and discovery to explore new treatment methods. Our products include Particle Counting and Characterization, Centrifugation, Flow Cytometry, Liquid Handling and Genomic solutions which are implemented in all major areas of Life Sciences such as biology, biochemistry, biophysics, nanotechnology and molecular biology to simplify and automate existing processes in the lab.
Booth N°3 | https://www.beckman.com/ | beckman_france@beckman.com
Created in 2012, following the French initiative of Technology Research Institutes, BIOASTER is a non-for-profit foundation developing a unique technological and innovative model to sup-port the latest challenges in microbiology. In particular, BIOASTER uses and develops high value technological innovations that accelerate development of medical solutions for populations and personalized medicine. The aim of BIOASTER is to bring together academic, industry and its capacities and specific knowledge to develop and execute high impact collaborative projects requiring industry compatible innovative technologies.
Key figures:
• 4 fields of expertise: antimicrobials, diagnostics, microbiome, vaccines
• BSL2 & BSL3 laboratories in Lyon and Paris
• 110+ employees, including 80% of scientific experts, 15 nationalities
• 330+ research contracts, involving 93 private partners, 54 public partners.
Booth N°16 | www.bioaster.org | olivier.charzat@bioaster.org
BIOTEM is a CRO/CMO which provides high added value services for the development / production of custom monoclonal antibodies and immunoassays since 1980.
Your Partner for Research, Diagnostics and Drug Discovery.
Booth N°20 | www.biotem-antibody.com/ | info@biotem.fr
30-year NCD/toxicology consulting, due diligence, ocular, cardiovasc, fundraising, partnerships. NCD plan, CRO selection, monitoring, reporting & submission to regulatory authorities (mainly EU/US). Global dvpt strategy In/outlicensing/partnership Due Dil support (startup, big pharma, investors).
Booth N°25 | www.capeval-pharma.com
Croda develops and supplies high purity pharmaceutical excipients to enhance delivery, efficacy, and stability of actives as well as highly performing vaccine adjuvants and in-house formulation expertise to aid in navigating drug and vaccine formulation challenges. Moreover, our lipid portfolio supports the delivery of mRNA-based vaccines.
With a product profile proven to stabilise, solubilise and to deliver the most challenging of active pharmaceutical ingredients and a substantial investment in GMP and multi-site EXCiPACT accreditation, Croda demonstrates confidence in both excipient quality and supply chain security.
Booth N°18 | www.crodapharma.com | Thomas.vinos-poyo@croda.com
ICTA is an international full-service CRO offering pharmaceutical, medical device professionals and biotech companies an end-to-end service for their product development in Europe and North America. Over our 40 years of experience we have developed a company culture and philosophy based on innovation, solution-finding, and work integrity.
Booth N°17 | www.icta.fr | remi.gauchoux@icta-group.com
Fort de plus de 60 ans d’expertise RH, Manpower accompagne PME et Grands Groupes dans le recrutement de profil experts et cadres en CDI, CDD, Intérim et Management de Transition.
Pour répondre à cette ambition, notre réseau de 50 agences Experts et Cadres est organisé en 9 hyperspécialisations : Finance, Engineering, Digital, Corporate, Construction, Sales & Marketing, Supply Chain, HR & Legal et Life Science.
Au cœur de votre bassin d’activité notre agence Manpower Life Science œuvre avec proactivité pour vous présenter les profils experts les plus adaptés à votre besoin.
En tant que Business Partners, nos consultants spécialisés vous apportent leur expertise RH et la connaissance pointue des métiers du médical, de la pharmacie, de la biotechnologie et de la santé pour que votre recrutement soit un succès.
Booth N°11 | www.manpower.fr | clement.fayard@manpower.fr | muriel.fossati@manpower.fr
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range.Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology.
Booth N°9 | olink.com | benjamin.britsch.fayet@olink.com
PEPperPRINT is the leading provider of high-density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses, trusted by researchers around the world with over 250 peer-reviewed publications.
Booth N°6 | https://www.pepperprint.com/ | info@pepperprint.com
Every Proteintech product is manufactured and validated in-house, meaning complete control over the quality and lot-to-lot consistency of its catalog. Proteintech’s comprehensive library of original validation data, product-specific protocols, and over 130,000 product citations enables you to publish faster with reproducible results.
Booth N°12 | https://www.ptglab.com/
Takis is a biotechnology company specialized in developing breakthrough immunotherapies for infectious disease and oncology fields. Founded in 2009 by a group of scientists from the multinational Merck & Co with over 20 years of experience in gene therapies and immunology, over the years Takis team has provided important direct contributions to the development of new vaccination platforms, including COVID-eVax, a DNA-based vaccine against COVID-19 proven to be safe and immunogenic in a first-in-human phase 1 trial. Recently, a BSL3 facility has been realized to perform in vitro and in vivo research activities with high-risk pathogens, and a GMP laboratory dedicated to clinical grade production of nucleic acids has been implemented. The company is also specialized in the research and development of potential oncological therapies, including cancer genetic vaccines and monoclonal antibodies, particularly humanized monoclonal antibodies designed for oncology and infectious diseases using in vivo electro-gene-transfer technology. Moreover, Takis offers fee-for-service options for preclinical in vitro and in vivo models, monoclonal antibody production, as well as for vaccine development. The company provides custom services for the generation of antibodies against poorly immunogenic antigens and for performing preclinical studies focused on immune-oncology research.
Booth N°7 | http://www.takisbiotech.it
